Showing results (121-130 of 171) with videos related to
Sort By:
Pageof 18
Brain Communications|September 21, 2020
Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophyRenske I Wadman, Marc D Jansen, Marloes Stam, et al.Journal of the Peripheral Nervous System : JPNS|June 27, 2015
Outcome measures in MMN revisited: further improvement neededMariëlle H J Pruppers, Thomas H P Draak, Els K Vanhoutte, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 9, 2025
Respiratory muscle activity and fatigue response during respiratory endurance testing in patients with spinal muscular atrophyKim Kant-Smits, Lisa Pomp, Laura E Habets, et al.Neurology|September 20, 2022
SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor NeuropathyAdája E Baars, Krista Kuitwaard, Laura C de Koning, et al.The Lancet. Neurology|May 3, 2017
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trialEnrico Bertini, Eric Dessaud, Eugenio Mercuri, et al.Journal of Neurology|January 1, 2015
Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control studyLotte Vlam, Sanne Piepers, Nadia A Sutedja, et al.European Journal of Neurology|December 10, 2025
Motor Unit Patterns Correlate With Severity in Symptomatic Patients With Spinal Muscular AtrophyLeandra A A Ros, W Ludo van der Pol, Diederik J L Stikvoort García, et al.BMJ Open|August 1, 2018
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial)Marloes Stam, Renske I Wadman, Camiel A Wijngaarde, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2015
Complement activity is associated with disease severity in multifocal motor neuropathyLotte Vlam, Elisabeth A Cats, Oliver Harschnitz, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 30, 2013
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathyKrista Kuitwaard, Pieter A van Doorn, Marinus Vermeulen, et al.Pageof 18